T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 81 filers reported holding T2 BIOSYSTEMS INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 1,400 | -85.5% | 0.00% | -100.0% |
| Q1 2022 | $12,000 | 0.0% | 9,680 | -5.8% | 0.00% | – |
| Q4 2021 | $12,000 | -14.3% | 10,280 | -17.0% | 0.00% | -100.0% |
| Q3 2021 | $14,000 | -6.7% | 12,380 | -32.6% | 0.00% | 0.0% |
| Q2 2021 | $15,000 | +7.1% | 18,380 | -19.4% | 0.00% | 0.0% |
| Q1 2021 | $14,000 | – | 22,800 | +3157.1% | 0.00% | – |
| Q4 2020 | $0 | – | 700 | +600.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 100 | -83.3% | 0.00% | – |
| Q4 2018 | $1,000 | -75.0% | 600 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | -87.1% | 600 | -90.3% | 0.00% | -100.0% |
| Q2 2018 | $31,000 | +244.4% | 6,200 | +287.5% | 0.00% | +100.0% |
| Q1 2018 | $9,000 | +800.0% | 1,600 | +700.0% | 0.00% | – |
| Q1 2017 | $1,000 | -83.3% | 200 | -97.2% | 0.00% | – |
| Q4 2016 | $6,000 | -33.3% | 7,100 | +173.1% | 0.00% | – |
| Q3 2016 | $9,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,841,924 | $13,722,000 | 6.87% |
| Senvest Management, LLC | 2,769,931 | $20,636,000 | 1.56% |
| Bell Rock Capital LLC | 291,835 | $2,176,000 | 1.07% |
| ARDSLEY ADVISORY PARTNERS LP | 935,000 | $6,966,000 | 0.94% |
| TIGER MANAGEMENT L.L.C. | 967,585 | $7,209,000 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 677,433 | $5,047,000 | 0.59% |
| THOMPSON DAVIS & CO., INC. | 33,153 | $247,000 | 0.54% |
| PERKINS CAPITAL MANAGEMENT INC | 69,700 | $519,000 | 0.31% |
| Schonfeld Strategic Advisors LLC | 322,700 | $2,404,000 | 0.11% |
| Phoenix Investment Adviser LLC | 8,000 | $60,000 | 0.08% |